| Daehan Nupharm Participates in Cosmoprof Bangkok to Accelerate Exports... Strengthening R&D and Facility Investment in Parallel 2025.06.26 | 
|---|
| Daehan Nupharm announced on the 26th that it is participating in “Cosmoprof CBE Asean Bangkok 2025”, which is currently being held in Bangkok, Thailand. The exhibition, hosted in Thailand’s rapidly growing beauty and medical aesthetics market (estimated at USD 6.6 billion), has been drawing increasing global attention since moving its venue to central Bangkok in 2023.  Thailand has shown strong and growing demand for K-beauty and Korean-made medical products, with imports rising significantly over the past three years.  Daehan Nupharm has been actively expanding its global presence, having completed overseas registration for 75 products to date, with 11 additional products registered in 2024 alone. The company has established a broad export network spanning Southeast Asia, Central Asia, the Middle East, South America, and New Zealand. Pharmaceutical product registration requires CTD (Common Technical Document) submissions, which include extensive data on raw materials, manufacturing processes, and toxicology studies. Because this process — including site inspections — can take several years depending on the country, a strategic approach backed by specialized expertise is essential. 
 Daehan Nupharm is pursuing a long-term export growth strategy ahead of the full operation of its new Hyangnam GMP facility in 2027.  | 


 Home
 Home